Literature DB >> 31538177

Cyclotriveratrylene-tethered trinuclear palladium(ii)-NHC complexes; reversal of site selectivity in Suzuki-Miyaura reactions.

Jonathan M Fowler1, Edward Britton, Christopher M Pask, Charlotte E Willans, Michaele J Hardie.   

Abstract

The trinuclear complexes [{PdI2(pyCl)}3(L1)] C1 and [{PdI2(pyCl)}3(L2)] C2, where pyCl = 3-chloropyridine, L1 = methyl(cyclotriguaiacylenyl)methylbenzimidazol-2-ylidene and L2 = benzyl(cyclotriguaiacylenyl)methylbenzimidazol-2-ylidene, each feature three palladium N-heterocyclic carbene (NHC) centres tethered onto a host-type cyclotriguaiacylene scaffold. Crystal structures of different solvates of complex C1 reveal different host-guest motifs including intra-cavity binding of dioxane guests concomitant with intramolecular halogen bonding interactions of C1. Mononuclear NHC analogues of C1 and C2, namely [PdI2(pyCl)(L3)] C3 and [PdI2(pyCl)(L4)] C4, where L3 = (3-chloropyridyl)-1-(2-methoxyphenyoxy)methyl-3-methylbenzimidazol-2-ylidene and L4 = (3-chloropyridyl)-1-(2-methoxyphenyoxy)methyl-3-benzylbenzimidazol-2-ylidene, were also synthesised and their crystal structures determined. Complexes C1-C4 are competent catalysts for Suzuki Miyaura cross-coupling, and interestingly exhibit a switch in the normal regioselectivity observed for reactions of 2,4-dibromopyridine with aryl boronic acids, usually C2-selective, yielding C4-arylated product preferentially over C2-arylated product.

Entities:  

Year:  2019        PMID: 31538177     DOI: 10.1039/c9dt03400e

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  1 in total

1.  A Dichotomy in Cross-Coupling Site Selectivity in a Dihalogenated Heteroarene: Influence of Mononuclear Pd, Pd Clusters, and Pd Nanoparticles-the Case for Exploiting Pd Catalyst Speciation.

Authors:  Neil W J Scott; Mark J Ford; Neda Jeddi; Anthony Eyles; Lauriane Simon; Adrian C Whitwood; Theo Tanner; Charlotte E Willans; Ian J S Fairlamb
Journal:  J Am Chem Soc       Date:  2021-06-21       Impact factor: 15.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.